Results 231 to 240 of about 915,973 (300)

Methodological challenges in Dutch HTA of non-oncological orphan drugs: a retrospective analysis and price comparison using different pricing models. [PDF]

Orphanet J Rare Dis
Walraven J, Kaveh M, Uyl-de Groot C.
europepmc   +1 more source

Growth of Omnichannel Grocery Retailing and Food Prices

Agribusiness, EarlyView.
ABSTRACT This paper examines the effects of the growth of omnichannel grocery retailing on food prices. We first develop a conceptual model of consumer choice and retailer pricing that allows us to evaluate changes in equilibrium prices, quantities, and profits with online channel growth and alternative pricing strategies.
Xiangwen Kong, Metin Çakır, Qingxiao Li   +2 more
wiley   +1 more source

Medicine Development and Access for Rare Diseases: Can We Do Better? [PDF]

J Inherit Metab Dis
Hollak CEM, Rosenberg N, Post C, Stolwijk N, Manders E, Schoenmakers D, Penninx B, Reijnhout N, Verdeyen K, Jonker R, Bosch AM, Langeveld M, van der Wel V, de Visser S, van den Berg S.   +14 more
europepmc   +1 more source

A distributionally robust bilevel optimization model for wholesale-retail electricity market design. [PDF]

Sci Rep
Jia X, Ji P, Chen F, Deng H, Chen M, Zhuang X, Qi X, Tan Z.   +7 more
europepmc   +1 more source

Implant prices and physician reimbursement have declined more than total costs and hospital payments in total shoulder arthroplasty. [PDF]

JSES Int
Yu JS, Wahle C, Heo K, Liu T, Sridharan M, Newman-Hung N, Petrigliano F, Jensen AR.   +7 more
europepmc   +1 more source

Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs. [PDF]

Health Econ Rev
Takamura K, Jinnai G, Niwa Y, Kondoh M.
europepmc   +1 more source

Collaborative optimization of computational offloading and resource allocation based on Stackelberg game. [PDF]

PLoS One
Li L, Yu Q, Wang C, Zhao J, Lv J, Wang S, Hu C.   +6 more
europepmc   +1 more source